These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 30808773)

  • 1. Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma.
    Kim S; Shin J; Kim DY; Choi GH; Kim MJ; Choi JY
    Clin Cancer Res; 2019 Jul; 25(13):3847-3855. PubMed ID: 30808773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
    Lee S; Kim SH; Lee JE; Sinn DH; Park CK
    J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
    Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
    Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
    Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
    Shim JH; Han S; Shin YM; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    J Magn Reson Imaging; 2015 Apr; 41(4):1115-23. PubMed ID: 24841479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T
    Wang WT; Zhu S; Ding Y; Yang L; Chen CZ; Ye QH; Ji Y; Zeng MS; Rao SX
    Eur J Radiol; 2018 Jun; 103():25-31. PubMed ID: 29803381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
    Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
    Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
    J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma.
    Yan Y; Lin XS; Ming WZ; Chuan ZQ; Hui G; Juan SY; Shuang W; Yang Fan LV; Dong Z
    Acad Radiol; 2024 Mar; 31(3):859-869. PubMed ID: 37689559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
    Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
    Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cox Nomogram for Assessing Recurrence Free Survival in Hepatocellular Carcinoma Following Surgical Resection Using Dynamic Contrast-Enhanced MRI Radiomics.
    Cao X; Yang H; Luo X; Zou L; Zhang Q; Li Q; Zhang J; Li X; Shi Y; Jin C
    J Magn Reson Imaging; 2023 Dec; 58(6):1930-1941. PubMed ID: 37177868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
    Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
    BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinoma.
    Lu Y; Wang H; Li C; Faghihkhorasani F; Guo C; Zheng X; Song T; Liu Q; Han S
    Eur J Surg Oncol; 2024 Sep; 50(9):108476. PubMed ID: 38870875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
    Kim YK; Kim CS; Han YM; Park G
    Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.